Listed

Celldex Therapeutics, Inc.: Form 10-Q for the period ended Sep 30, 2015

Filed with the SEC on Nov 5, 2015 and accepted by EDGAR at Nov 5, 2015, 17:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-07-01 to 2015-09-30$1.0mus-gaap:Revenues
Revenue9 months2015-01-01 to 2015-09-30$3.7mus-gaap:Revenues
Research and development3 months2015-07-01 to 2015-09-30$24.7mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2015-01-01 to 2015-09-30$76.3mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2015-07-01 to 2015-09-30−$32.4mus-gaap:OperatingIncomeLoss
Operating income9 months2015-01-01 to 2015-09-30−$96.1mus-gaap:OperatingIncomeLoss
Net income3 months2015-07-01 to 2015-09-30−$32.0mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income9 months2015-01-01 to 2015-09-30−$94.5mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2015-07-01 to 2015-09-30−$0.32us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2015-01-01 to 2015-09-30−$0.98us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2015-01-01 to 2015-09-30−$85.1mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure9 months2015-01-01 to 2015-09-30$4.5mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-09-30$66.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-09-30$309.3mus-gaap:AssetsCurrent
Total assetsAt period end2015-09-30$352.6mus-gaap:Assets
Current liabilitiesAt period end2015-09-30$23.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-09-30$34.0mus-gaap:Liabilities
Shareholders' equityAt period end2015-09-30$318.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-15-076295. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.